BioSpace News Archive

AcelRx Pharmaceuticals Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, today announced that management will be presenting at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced that it has completed enrollment for the AURORA Phase 3 trial ahead of schedule.

SurGenTec ® LLC has been awarded the 2018 Orthopedics This Week Spine Technology Award and will be formally receiving their award during the 2018 North American Spine Society meeting.

Hard-hitting bus shelter advertisements near D.C. hospitals will urge patients and others to #BreakUpWithBacon to prevent colon cancer.

Aldeyra Therapeutics, Inc. today announced it will hold a webcast and conference call on Wednesday, September 26, 2017 at 8:00 a.m. EDT to provide the results from its dry eye disease Phase 2b clinical trial.

Verastem Oncology to Receive an Upfront Payment of $15 Million USD; Then Eligible to Receive Up To $30 Million USD in Development Milestone Payments as well as Sales Milestone and Double-Digit Percentage Royalty Payments

Provata Health Recalls Promotional Activity Trackers

BRUSTIN & LUNDBLAD, LTD. won a jury verdict in the amount of $18,500,000.00 on behalf of a 12-year old boy who was injured by the prescription of a mental health drug to his mother when he was in the fetal stage.

More than 80% of Required Infusions Now Successfully Administered in Adult Portion of Study